Bavarian Nordic's Covid-19 booster candidate to be tested on 3,000 volunteers
The Danish vaccine maker is facing a crucial test, says the study’s leader in Denmark, before data can be processed for a potential marketing authorization application in 2024 at the earliest.
by Ritzau, translated by daniel pedersen
A booster vaccine developed by Bavarian Nordic and Adaptvac against Covid-19 will be tried on 3,000 volunteers from Denmark, Belgium, and the US.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
